Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)-Cas systems have revolutionized the field of genetic engineering, offering a precise and efficient platform for genome editing.  This technology, initially discovered as a bacterial defense mechanism against bacteriophages, has been adapted for widespread use in diverse organisms, from microorganisms to mammals.  Its ease of use, coupled with high specificity and relatively low cost, distinguishes CRISPR from previous gene editing techniques like Zinc Finger Nucleases (ZFNs) and Transcription Activator-Like Effector Nucleases (TALENs).  This paper will explore the mechanisms of CRISPR-Cas systems, focusing primarily on the widely adopted CRISPR-Cas9 system, and will delve into its diverse practical applications.  These applications span a broad spectrum, including therapeutic interventions for genetic diseases such as sickle cell anemia and cystic fibrosis, where precise gene correction holds immense promise.  Furthermore, CRISPR technology facilitates advancements in agricultural biotechnology through the development of crop varieties with enhanced nutritional content and disease resistance.  Beyond therapeutic and agricultural contexts, CRISPR is proving invaluable in fundamental biological research, enabling functional genomics studies and the creation of sophisticated cellular and animal models for disease.  This review will synthesize current research, highlighting both the transformative potential and the associated ethical considerations surrounding this powerful technology.